Header Logo

Connection

MUHAMMAD SOHAIL to Prosthesis-Related Infections

Back to Details
This is a "connection" page, showing publications MUHAMMAD SOHAIL has written about Prosthesis-Related Infections.
MUHAMMAD SOHAIL
Connection Strength
14.457
Prosthesis-Related Infections
  1. Discriminative Ability and Reliability of Transesophageal Echocardiography in Characterizing Cases of Cardiac Device Lead Vegetations Versus Noninfectious Echodensities. Clin Infect Dis. 2021 06 01; 72(11):1938-1943.
    View in: PubMed
    Score: 0.634
  2. Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial. JACC Clin Electrophysiol. 2021 01; 7(1):50-61.
    View in: PubMed
    Score: 0.609
  3. Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope. Pacing Clin Electrophysiol. 2020 03; 43(3):341-349.
    View in: PubMed
    Score: 0.582
  4. Infection Management. Card Electrophysiol Clin. 2018 12; 10(4):601-607.
    View in: PubMed
    Score: 0.533
  5. Single Versus Multidrug Regimen for Surgical Infection Prophylaxis in Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):735-740.
    View in: PubMed
    Score: 0.530
  6. Approach to Diagnosis of Cardiovascular Implantable-Electronic-Device Infection. J Clin Microbiol. 2018 07; 56(7).
    View in: PubMed
    Score: 0.517
  7. Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol. 2018 05; 41(5):495-503.
    View in: PubMed
    Score: 0.508
  8. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2019 06; 26(3):958-970.
    View in: PubMed
    Score: 0.490
  9. Prevalence and antibiogram of methicillin resistant Staphylococcus aureus isolated from medical device-related infections; a retrospective study in Lahore, Pakistan. Rev Soc Bras Med Trop. 2017 Sep-Oct; 50(5):680-684.
    View in: PubMed
    Score: 0.489
  10. Strategies to prevent infections associated with cardiovascular implantable electronic devices. Expert Rev Med Devices. 2017 May; 14(5):371-381.
    View in: PubMed
    Score: 0.478
  11. Helcococcus kunzii prosthetic valve endocarditis secondary to lower extremity cellulitis. BMJ Case Rep. 2017 May 03; 2017.
    View in: PubMed
    Score: 0.478
  12. Management of bacteremia in patients living with cardiovascular implantable electronic devices. Heart Rhythm. 2016 11; 13(11):2247-2252.
    View in: PubMed
    Score: 0.455
  13. Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation. Circ Arrhythm Electrophysiol. 2016 08; 9(8).
    View in: PubMed
    Score: 0.454
  14. Clinical Presentation, Risk Factors, and Outcomes of Hematogenous Prosthetic Joint Infection in Patients with Staphylococcus aureus Bacteremia. Am J Med. 2016 Feb; 129(2):221.e11-20.
    View in: PubMed
    Score: 0.429
  15. Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol. 2015 Apr 01; 115(7):912-7.
    View in: PubMed
    Score: 0.407
  16. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):137-44.
    View in: PubMed
    Score: 0.405
  17. Cardiovascular implantable electronic device infections in left ventricular assist device recipients. Pacing Clin Electrophysiol. 2014 Feb; 37(2):225-30.
    View in: PubMed
    Score: 0.371
  18. Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device. Am J Cardiol. 2013 Nov 01; 112(9):1403-9.
    View in: PubMed
    Score: 0.370
  19. Current concepts in the diagnosis and management of left ventricular assist device infections. Expert Rev Anti Infect Ther. 2013 Feb; 11(2):201-10.
    View in: PubMed
    Score: 0.356
  20. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011 Nov 14; 171(20):1821-8.
    View in: PubMed
    Score: 0.323
  21. Cardiovascular implantable electronic device infection: a stepwise approach to diagnosis and management. Cleve Clin J Med. 2011 Aug; 78(8):529-37.
    View in: PubMed
    Score: 0.321
  22. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol. 2011 Aug; 31(2):171-83.
    View in: PubMed
    Score: 0.312
  23. Contemporary management of cardiovascular implantable electronic device infections. Expert Rev Anti Infect Ther. 2010 Jul; 8(7):831-9.
    View in: PubMed
    Score: 0.297
  24. Infective endocarditis due to Propionibacterium species. Clin Microbiol Infect. 2009 Apr; 15(4):387-94.
    View in: PubMed
    Score: 0.271
  25. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008 Jan; 83(1):46-53.
    View in: PubMed
    Score: 0.250
  26. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007 Jul 15; 45(2):166-73.
    View in: PubMed
    Score: 0.240
  27. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007 May 08; 49(18):1851-9.
    View in: PubMed
    Score: 0.238
  28. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med. 2006 Feb; 119(2):147-54.
    View in: PubMed
    Score: 0.219
  29. Pathogen influence on epidemiology, diagnostic evaluation and management of infective endocarditis. Heart. 2020 12; 106(24):1878-1882.
    View in: PubMed
    Score: 0.150
  30. Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019 10; 42(10):1331-1339.
    View in: PubMed
    Score: 0.140
  31. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A?Population-Based Study. JACC Clin Electrophysiol. 2019 09; 5(9):1071-1080.
    View in: PubMed
    Score: 0.140
  32. Contemporary management of cardiac implantable electronic device infection. Heart. 2019 06; 105(12):961-965.
    View in: PubMed
    Score: 0.135
  33. Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success? Pacing Clin Electrophysiol. 2018 05; 41(5):524-531.
    View in: PubMed
    Score: 0.127
  34. Impact of Abandoned Leads on Cardiovascular Implantable Electronic?Device Infections: A?Propensity Matched Analysis of MEDIC (Multicenter?Electrophysiologic Device Infection?Cohort). JACC Clin Electrophysiol. 2018 02; 4(2):201-208.
    View in: PubMed
    Score: 0.124
  35. Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation. J Interv Card Electrophysiol. 2017 Oct; 50(1):117-124.
    View in: PubMed
    Score: 0.122
  36. Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis. 2017 Jun 01; 64(11):1516-1521.
    View in: PubMed
    Score: 0.120
  37. Antibacterial Envelope Is Associated With?Low Infection Rates After Implantable Cardioverter-Defibrillator and?Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. JACC Clin Electrophysiol. 2017 10; 3(10):1158-1167.
    View in: PubMed
    Score: 0.120
  38. Reimplantation and Repeat Infection After Cardiac-Implantable Electronic Device Infections: Experience From the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Database. Circ Arrhythm Electrophysiol. 2017 Mar; 10(3).
    View in: PubMed
    Score: 0.118
  39. Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves. Circ Arrhythm Electrophysiol. 2016 09; 9(9).
    View in: PubMed
    Score: 0.114
  40. Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species. Pacing Clin Electrophysiol. 2016 Jun; 39(6):522-30.
    View in: PubMed
    Score: 0.111
  41. Role of PET Imaging in Management of Implantable Electronic Device Infection. JACC Cardiovasc Imaging. 2016 Mar; 9(3):291-3.
    View in: PubMed
    Score: 0.110
  42. Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry. JACC Cardiovasc Imaging. 2014 Jun; 7(6):541-9.
    View in: PubMed
    Score: 0.097
  43. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections. Pacing Clin Electrophysiol. 2014 Aug; 37(8):955-62.
    View in: PubMed
    Score: 0.096
  44. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013 Nov; 57(10):1438-48.
    View in: PubMed
    Score: 0.092
  45. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol. 2013 Mar 15; 111(6):874-9.
    View in: PubMed
    Score: 0.088
  46. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013 Feb; 15(2):227-35.
    View in: PubMed
    Score: 0.087
  47. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012 Oct 15; 110(8):1143-9.
    View in: PubMed
    Score: 0.085
  48. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012 Feb 14; 59(7):681-7.
    View in: PubMed
    Score: 0.083
  49. Cardiac device-related endocarditis complicated by spinal abscess. Pacing Clin Electrophysiol. 2012 Mar; 35(3):269-74.
    View in: PubMed
    Score: 0.082
  50. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011 Nov; 8(11):1678-85.
    View in: PubMed
    Score: 0.079
  51. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011 Apr; 34(4):450-9.
    View in: PubMed
    Score: 0.077
  52. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol. 2011 Feb; 34(2):133-42.
    View in: PubMed
    Score: 0.076
  53. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus. Circ Arrhythm Electrophysiol. 2010 Dec; 3(6):639-45.
    View in: PubMed
    Score: 0.075
  54. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010 Apr; 33(4):407-13.
    View in: PubMed
    Score: 0.071
  55. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007 Apr 09; 167(7):669-75.
    View in: PubMed
    Score: 0.059
  56. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis. 2006 Sep 15; 43(6):731-6.
    View in: PubMed
    Score: 0.057
  57. Corynebacterium jeikeium prosthetic joint infection: case report and literature review. Scand J Infect Dis. 2005; 37(2):151-3.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.